Leadhexa


San Francisco, CA

Alumni
Leadhexa

Leadhexa Biotechnologies, Inc. is a Delaware corporation, whose founders have discovered a unique version of the enzyme Manganese SuperOxide Dismutase (MnSOD) which stunningly has the ability to enter cells and mitochondria.  

The molecule has demonstrated efficacy in numerous preclinical models including actinic keratosis, tumor suppression, radiation protection, protection of kidney damage due to cyclosporine or contrast dye, liver cirrhosis and liver ischemia-reperfusion injury.  

Leadhexa is an early-stage startup incubated at QB3 in San Francisco and is actively seeking venture investment in order to start advancing its molecules towards clinical trials.